World's Best Scientists 2026 revealed!
Award Badge
Medicine
Italy
2023

D-Index & Metrics

Medicine

D-Index
124
Citations
81308
World Ranking
3157
National Ranking
85

Umberto Veronesi publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Umberto Veronesi sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 560 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Umberto Veronesi D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Umberto Veronesi sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 124 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Italy Leader Award
  • 2003 - King Faisal Prize

Overview

Umberto Veronesi was affiliated with the European Institute of Oncology in Italy. Their research largely focused on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with particular attention to Cancer Research, Pathology and Forensic Medicine, and Oncology.

Their work covered several main topics, including:

  • Breast Cancer Treatment Studies
  • Breast Lesions and Carcinomas
  • Cancer Cells and Metastasis

Among their recent publications were the following papers:

  • Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial (2021, The Lancet Oncology)
  • Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14,324 women in 16 trials (2023, The Lancet)

They frequently collaborated with other researchers in their field. Notable coauthors included Viviana Galimberti, Stefano Zurrida, Roberto Orecchia, Patrick Maisonneuve, and Roberta Lazzari.

Veronesi received the King Faisal Prize in 2003.

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast Cancer

    Umberto Veronesi;Natale Cascinelli;Luigi Mariani;Marco Greco

  • Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

    C Focan;SM Steinberg;M Blichert-Toft;JF Forbes

  • A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.

    Umberto Veronesi;Giovanni Paganelli;Giuseppe Viale;Alberto Luini

  • Comparing Radical Mastectomy with Quadrantectomy, Axillary Dissection, and Radiotherapy in Patients with Small Cancers of the Breast

    Veronesi U;Saccozzi R;Del Vecchio M;Banfi A

  • Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

    Bonadonna G;Brusamolino E;Valagussa P;Rossi A

  • Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

    Viviana Galimberti;Bernard F. Cole;Bernard F. Cole;Stefano Zurrida;Giuseppe Viale;Giuseppe Viale

  • Overview of the main outcomes in breast-cancer prevention trials.

    J Cuzick;T Powles;U Veronesi;J Forbes

  • Radiotherapy after Breast-Preserving Surgery in Women with Localized Cancer of the Breast

    Umberto Veronesi;Alberto Luini;Marcella Del Vecchio;Marco Greco

  • Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series.

    U Veronesi;G Paganelli;G Viale;V Galimberti

  • Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women

    U Veronesi;P Maisonneuve;A Costa;V Sacchini

  • Breast cancer (1)

    Jay R. Harris;Marc E. Lippman;Umberto Veronesi;Walter Willett

  • Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial

    U. Veronesi;E. Marubini;L. Mariani;V. Galimberti

  • Inefficacy of Immediate Node Dissection in Stage 1 Melanoma of the Limbs

    Veronesi U;Adamus J;Bandiera Dc;Brennhovd Io

  • Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial

    Umberto Veronesi;Roberto Orecchia;Roberto Orecchia;Patrick Maisonneuve;Giuseppe Viale;Giuseppe Viale

  • Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or More

    Gianni Bonadonna;Umberto Veronesi;Cristina Brambilla;Laura Ferrari

  • Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study.

    Umberto Veronesi;Giuseppe Viale;Giovanni Paganelli;Stefano Zurrida

  • Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events.

    Umberto Veronesi;Ettore Marubini;Marcella Del Vecchio;Antonia Manzari

  • Thin Stage I Primary Cutaneous Malignant Melanoma

    Umberto Veronesi;Natale Cascinelli;Jerzy Adamus;Jerzy Adamus;Charles M Balch

  • Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes

    U. Veronesi;G. Paganelli;V. Galimberti;G. Viale

Frequent Co-Authors

Paolo Veronesi
Paolo Veronesi European Institute of Oncology
Viviana Galimberti
Viviana Galimberti European Institute of Oncology
Giuseppe Viale
Giuseppe Viale University of Milan
Roberto Orecchia
Roberto Orecchia European Institute of Oncology
Nicole Rotmensz
Nicole Rotmensz European Institute of Oncology
Patrick Maisonneuve
Patrick Maisonneuve European Institute of Oncology
Giovanni Paganelli
Giovanni Paganelli Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Alberto Luini
Alberto Luini National Research Council (CNR)
Bernardo Bonanni
Bernardo Bonanni European Institute of Oncology
Peter Boyle
Peter Boyle University of Edinburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring a future in medicine but seeking alternative or supportive career routes, a variety of online programs are available. For those interested in the administrative side of healthcare, online healthcare administration degree programs offer a fast and flexible way to gain leadership and management skills in the healthcare industry.

Entry-level healthcare positions are also accessible through specialized training. Consider medical coding and billing classes online with financial aid, which prepare you for crucial roles in managing patient data, insurance claims, and healthcare reimbursement—all from home.

For those drawn to patient care, nursing remains a rewarding pathway. You can enroll in nursing programs without teas if you want to bypass standardized pre-admission tests, speeding up your entry into the field.

Advancing from registered nurse to nurse practitioner is easier with options like adn to fnp bridge programs. These flexible online tracks help licensed nurses move up the professional ladder, opening greater opportunities in clinical practice and leadership.

Best Scientists Citing Umberto Veronesi